Voluntary ex ante transparency notice
Directive 2014/24/EU
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership
Procurement Department, Cardiff and Vale University Local Health Board, Brecknock House, 8th Floor, University Hospital of Wales, Heath Park,
Cardiff
CF14 4XW
UK
Contact person: Jacob Stokes
Telephone: +44 2920743261
E-mail: Jacob.Stokes@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://www.procurement.wales.nhs.uk
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Purchase of Triple Quadrupole Tandem Mass Spectrometer
Reference number: 18/2584
II.1.2) Main CPV code
38000000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Cardiff & Vale uLHB intends to purchase an TRIPLE QUAD 5500 system to improve and increase the performance of a multitude of assays including plasma/ urine metadrenalines and 17-hydroxy Progesterone in serum, saliva and bloodspots, unattended autosampling and continuous running of samples in a 24 hour period. This equipment will be compatible with existing AB Sciex platforms. The purchase will include associated maintenance service plan.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
193 881.45
GBP
II.2) Description
II.2.2) Additional CPV code(s)
38000000
II.2.3) Place of performance
NUTS code:
UKL22
Main site or place of performance:
University Hospital of Wales
II.2.4) Description of the procurement
There is a requirement for a triple quadrupole tandem mass spectrometer fitted with an interchangeable ionisation source. It must have a liquid chromatography unit with an automated sample introduction. The instrument must be able to perform a multitude of assays including plasma/ urine metadrenalines and 17-hydroxy Progesterone in serum, saliva and bloodspots. Unattended autosampling and continuous running of samples in a 24 hour period should be possible. A computer system should be supplied capable of running the tandem mass spectrometer and sampling system, as well as analysing the mass spectral data to produce results in a reportable format.
The laboratory currently operate other AB Sciex instruments sensitive enough for measurement of plasma metadrenalines/salivary samples. To minimise clinical disruption through method development times, compatibility and interfacing issues, and staff training and it is imperative that the new instrument would replicate the existing system exactly. This will mean current methods will be able to be transferred across with no new development work required. This will also reduce the implementation time of the new system into our clinical service and ensure we provide a robust service for our clinical users. Training requirements will be reduced which will allow allocation of staff time to further development, future-proofing our clinical service. For this reason, no other supplier is considered.
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation:
he laboratory currently operate other AB Sciex instruments sensitive enough for measurement of plasma metadrenalines/salivary samples. To minimise clinical disruption through method development times, compatibility and interfacing issues, and staff training and it is imperative that the new instrument would replicate the existing system exactly. This will mean current methods will be able to be transferred across with no new development work required. This will also reduce the implementation time of the new system into our clinical service and ensure we provide a robust service for our clinical users. Training requirements will be reduced which will allow allocation of staff time to further development, future-proofing our clinical service. For this reason, no other supplier is considered.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract/concession
Contract No: 18/2584
V.2 Award of contract/concession
V.2.1) Date of conclusion of the contract/concession
22/02/2019
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
AB Sciex UK Limited (operating as SCIEX)
Phoenix House, Lakeside Drive, Centre Park, Warrington
Cheshire
WA1 1RX
UK
Telephone: +44 1925236042
E-mail: vicki.gallant@sciex.com
Fax: +44 80022552271
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the concession and main financing terms (excluding VAT)
Total value of the concession/lot:
193 881.45
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=90097.
(WA Ref:90097)
VI.4) Procedures for review
VI.4.1) Review body
NHS Wales Shared Services Partnership
Procurement Department, Cardiff and Vale University Local Health Board, Brecknock House, 8th Floor, University Hospital of Wales, Heath Park
Cardiff
CF14 4XW
UK
Telephone: +44 2920743261
E-mail: Jacob.Stokes@wales.nhs.uk
Internet address(es)
URL: http://www.procurement.wales.nhs.uk
VI.5) Date of dispatch of this notice
22/02/2019